Board Name | Posts By Nicolemarie7595 | Post Created |
---|---|---|
NASDAQ DIP and RIP | Check out - $PZRX - Looking like a (1) | 07/05/2017 10:34:30 AM |
Momentum Players | Check out - $PZRX - Looking like a | 07/05/2017 10:34:04 AM |
Xtremepicks Alerts | Check out - $PZRX - Looking like a | 07/05/2017 10:33:30 AM |
The Hot Zone | Check out - $PZRX - Looking like a | 07/05/2017 10:32:54 AM |
CRGP Calissio Resources Group, Inc. | Right now... I'm watching OREX. Jus | 04/28/2016 9:39:13 AM |
OREXQ Orexigen Therapeutics | Orexigen Announces Upcoming Present | 04/28/2016 9:35:08 AM |
CRGP Calissio Resources Group, Inc. | Woohoo! Great news. What a relief. | 11/10/2015 4:34:51 PM |
CRGP Calissio Resources Group, Inc. | 350K | 09/30/2015 4:31:58 PM |
CRGP Calissio Resources Group, Inc. | That is kind of funny that so many | 09/23/2015 9:59:15 AM |
Recent Articles
- U-Haul Unveils State-of-the-Art Full-Service Center in Town
- Bunge Announces Important Q4 2024 Earnings Call Details
- ProMIS Neurosciences Launches Pioneering Alzheimer’s Study
- INE Earns Recognition for Excellence in Cybersecurity Training
- Experience the Future of Psychology at ACAP 2025 Conference
- Exploring the Expanding Biologics Market: Trends and Insights
- Last Chance to Experience Epic Finale of Dubai Shopping Festival
- Quanterix and Akoya Merger: A New Era in Biomarker Detection
- iTeos Therapeutics Reveals Strategic Goals for Advancement
- International Perspectives on China's Growth: A Global Survey Insight
- BioCryst Pharmaceuticals Forecasts Strong ORLADEYO Sales Growth
- Wellness Real Estate Market Set for Exponential Growth
- Nigeria and US Finalize Agreement on $52.88 Million Repatriation
- Rhythm Pharmaceuticals Reports Strong Q4 2024 Revenues and Plans Ahead
- Impact of Wildfires on U.S. Property Insurance Sector
- Royalty Pharma's Strategic Move: A New Chapter in Growth
- Nvidia's Unmatched Growth Potential in AI Explored
- Alliance Witan PLC Announces Updated Net Asset Value Metrics
- Pfizer Advances Bladder Cancer Treatment with Study Success
- Crinetics Reveals Promising Results for Atumelnant in CAH Trials
- Bank of America Raises Concerns on S&P 500 Valuation Metrics
- Abaxx Technologies Debuts Nickel Sulphate Futures for Traders
- Walgreens Boots Reports Better-Than-Expected Earnings Results
- Green Thumb Industries Partners with Iconic Chicago Venue
- Constellation Energy Expands Reach with $26.6 Billion Acquisition
- Join Amplify Energy's Insightful Chat with Alliance Global Partners
- EnviroGold Global Expands Unit Offering to Meet Investor Demand
- Plymouth Industrial REIT's Strong Finish and Future Outlook
- Next Health Expands Its Vision with New Nashville Location
- Señorita Partners with Salt Shed to Revolutionize Concert Experiences
- Spero Therapeutics Appoints New Interim Leadership and Update on Trials
- Experience Unmatched Audio with Cooler Master's CH351 Headset
- Bio-Path Holdings Reveals 2025 Strategy for Cancer Treatments
- Recent Developments for Aspo: Board Member Charges Dropped
- Quanterix and Akoya Merger: A Game Changer in Biomarker Detection
- EDAP TMS Strengthens Board with Joshua H. Levine's Appointment
- New Leaders Bring Fresh Energy to RMHC Bay Area Board
- Immunocore Sets Ambitious Goals for 2025 at Industry Conference
- Chemtrade Logistics Welcomes New Board Member: Suzann Pennington
- Leadership Transition at NeoGenomics as Chris Smith Retires
- Significant Milestones for GH Research in Psychiatric Trials
- Arvinas Unveils New Developments and Future Plans for Trials
- The New York Stem Cell Foundation's Innovative Drug Discovery Partnership
- BioCryst Pharmaceuticals Reports Strong Revenue Growth for ORLADEYO
- D-Wave Quantum Inc. Reports Increased Bookings of $23 Million
- Marengo Therapeutics to Showcase Advances at Healthcare Event
- Invivyd Reports Strong Neutralizing Effect of PEMGARDA™ Against New COVID Variants
- Discover Pairzon's Revolutionary Marketing Optimization Tool
- Xeris Biopharma Anticipates Record Revenue Growth for 2024
- Y-mAbs Announces Strategic Shift and Future Milestones Ahead